In the last decade, gene therapy treatments for people with sickle cell disease (SCD) have made huge advances. What are the promises and perils of gene editing for SCD, a devastating condition that impacts about 100,000 people across the United States? Download the white paper to learn more.
June 5, 2024
White Paper
The Promises and Perils of Gene Editing for Sickle Cell
View all topics